Proteomics for the diagnosis of thyroid lesions: Preliminary report

Cytopathology

Volumn 26, Issue 5, 2015, Pages 318-324

  Pagni, F ^a   Mainini, V ^b   Garancini, M ^a   Bono, F ^a   Vanzati, A ^a   Giardini, V ^a   Scardilli, M ^a   Goffredo, P ^a   Smith, A J ^b   Galli, M ^b   De Sio, G ^b   Magni, F ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Fine needle aspiration cytology; Imaging mass spectrometry; MALDI IMS; thyroid follicular lesions; Matrix assisted laser desorption ionization; Thyroid carcinoma; proteomics

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER PATIENT; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EX VIVO STUDY; FEASIBILITY STUDY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEOMICS; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID NODULE; ADULT; AGED; CARCINOMA; FEMALE; MALE; MEDULLARY CARCINOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; THYROID GLAND; THYROID NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BIOPSY, FINE-NEEDLE; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, NEUROENDOCRINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84942103529     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/cyt.12166     Document Type: Article

References (12)

1. Pagni F, Prada M, Goffredo P et al. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact. Cytopathology 2014;25:170-6.
2. Seningen JL, Nassar A, Henry MR. Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: an institutional experience of 1, 945 cases. Diagn Cytopathol 2012;40(Suppl 1):E27-32.
3. Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009;19:1167-214.
4. Nikiforov YE, Ohori NP, Hodak SP et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011;96:3390-7.
5. Alexander EK, Kennedy GC, Baloch ZW et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 2012;367:705-15.
6. Ohori NP, Nikiforova MN, Schoedel KE et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance". Cancer Cytopathol 2010;118:17-23.
7. Schwamborn K. Imaging mass spectrometry in biomarker discovery and validation. J Proteomics 2012;75:4990-8.
8. Mainini V, Pagni F, Garancini M et al. An alternative approach in endocrine pathology research: MALDI-IMS in papillary thyroid carcinoma. Endocr Pathol 2013;24:250-3.
9. Ciregia F, Giusti L, Molinaro A et al. Presence in the presurgical Fine Needle Aspiration of potential thyroid biomarkers previously identified in the post-surgical one. PLoS ONE 2013;8:e72911.
10. Krause K, Schierhorn A, Sinz A et al. Toward the application of proteomics to human thyroid tissue. Thyroid 2006;16:1131-43.
11. Giusti L, Iacconi P, Ciregia F et al. Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J Proteome Res 2008;7:4079-88.
12. Yazgan A, Balci S, Dincer N et al. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology. Cytopathology 2013;25:185-9.